投稿ビュー
Roche buys into SQZ engineering tech in $500m deal - PharmaTimes
Roche buys into SQZ engineering tech in $500m deal PharmaTimes SQZ' pioneering technology is based on engineering B cells to fight cancer. Proteins are introduced into a patient's B cells to activate killer T cells to attack cancer cells, offering a novel approach which the firms say could overcome many of the ... Roche allies with cell engineering startup SQZ on $500M+ immuno-oncology pact SQZ Biotech Announces Partnership to Fight Cancer with Novel Cell Engineering ... |
投稿情報
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"